Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease

Abstract

N-terminal pro-BNP is a potential biomarker for risk stratification and therapeutic decision-making in patients with 3VD. Further randomized studies are needed to confirm these findings.